Exploration of first onsets of mania, schizophrenia spectrum disorders and major depressive disorder in perimenopause

被引:0
|
作者
Lisa M. Shitomi-Jones [1 ]
Clare Dolman [2 ]
Ian Jones [1 ]
George Kirov [3 ]
Valentina Escott-Price [1 ]
Sophie E. Legge [1 ]
Arianna Di Florio [1 ]
机构
[1] Cardiff University,Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine
[2] Bipolar UK,National Centre for Mental Health, School of Medicine
[3] Cardiff University,undefined
来源
Nature Mental Health | 2024年 / 2卷 / 10期
关键词
D O I
10.1038/s44220-024-00292-4
中图分类号
学科分类号
摘要
Although the relationship between perimenopause and changes in mood has been well established, knowledge of risk of a broad spectrum of psychiatric disorders associated with reproductive aging is limited. Here we investigate whether the perimenopause (that is, the years around the final menstrual period (FMP)) is associated with increased risk of developing psychiatric disorders compared with the late reproductive stage. Information on menopausal timing and psychiatric history was obtained from nurse-administered interviews and online questionnaires from 128,294 female participants within UK Biobank. Incidence rates of psychiatric disorders during the perimenopause (4 years surrounding the FMP) were compared with the reference premenopausal period (6–10 years before the FMP). The rates were calculated for major depressive disorder (MDD), mania, schizophrenia spectrum disorders and other diagnoses. Overall, of 128,294 participants, 753 (0.59%) reported their first onset of a psychiatric disorder during the late reproductive stage (incidence rate 1.53 per 1,000 person-years) and 1,133 (0.88%) during the perimenopause (incidence rate 2.33 per 1,000 person-years). Compared with the reference reproductive period, incidence rates of psychiatric disorders significantly increased during the perimenopause (incidence rate ratio (RR) of 1.52, 95% confidence interval (CI) 1.39–1.67) and decreased back down to that observed in the premenopausal period in the postmenopause (RR of 1.09 (95% CI 0.98–1.21)). The effect was primarily driven by increased incidence rates of MDD, with an incidence RR of 1.30 (95% CI 1.16–1.45). However, the largest effect size at perimenopause was observed for mania (RR of 2.12 (95% CI 1.30–3.52)). No association was found between perimenopause and incidence rates of schizophrenia spectrum disorders (RR of 0.95 (95% CI 0.48–1.88)). In conclusion, perimenopause was associated with an increased risk of developing MDD and mania. No association was found between perimenopause and first onsets of schizophrenia spectrum disorders.
引用
收藏
页码:1161 / 1168
页数:7
相关论文
共 50 条
  • [31] Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
    Rollins, Brandi
    Martin, Maureen V.
    Sequeira, P. Adolfo
    Moon, Emily A.
    Morgan, Ling Z.
    Watson, Stanley J.
    Schatzberg, Alan
    Akil, Huda
    Myers, Richard M.
    Jones, Edward G.
    Wallace, Douglas C.
    Bunney, William E.
    Vawter, Marquis P.
    PLOS ONE, 2009, 4 (03):
  • [32] The severity of inflammation in major neuropsychiatric disorders: comparison of neutrophil-lymphocyte and platelet-lymphocyte ratios between schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and obsessive compulsive disorder
    Bulut, Necati Serkut
    Yorguner, Nese
    Carkaxhiu Bulut, Gresa
    NORDIC JOURNAL OF PSYCHIATRY, 2021, 75 (08) : 624 - 632
  • [33] Major Depressive Disorder in View of Bipolar Spectrum
    Hashorva, A.
    Suli, A.
    Spaho, E.
    Themeli, Y.
    Ulqinaku, D.
    Alikaj, V.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [34] Verbal affordances of active and receptive music therapy methods in major depressive disorder and schizophrenia-spectrum disorder
    Lotter, Carol
    van Staden, Werdie
    ARTS IN PSYCHOTHERAPY, 2019, 64 : 59 - 68
  • [35] Automaticity in anxiety disorders and major depressive disorder
    Teachman, Bethany A.
    Joormann, Jutta
    Steinman, Shari A.
    Gotlib, Ian H.
    CLINICAL PSYCHOLOGY REVIEW, 2012, 32 (06) : 575 - 603
  • [36] Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
    Maier, Robert
    Moser, Gerhard
    Chen, Guo-Bo
    Ripke, Stephan
    Coryell, William
    Potash, James B.
    Scheftner, William A.
    Shi, Jianxin
    Weissman, Myrna M.
    Hultman, Christina M.
    Landen, Mikael
    Levinson, Douglas F.
    Kendler, Kenneth S.
    Smoller, Jordan W.
    Wray, Naomi R.
    Lee, S. Hong
    AMERICAN JOURNAL OF HUMAN GENETICS, 2015, 96 (02) : 283 - 294
  • [37] Clinical Staging of Major Depressive Disorder: An Empirical Exploration
    Verduijn, Judith
    Milaneschi, Yuri
    van Hemert, Albert M.
    Schoevers, Robert A.
    Hickie, Ian B.
    Penninx, Brenda W. J. H.
    Beekman, Aartjan T. F.
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (09) : 1200 - 1208
  • [38] Clinical staging of major depressive disorder: an empirical exploration
    Verduijn, Judith
    Milaneschi, Yuri
    Beekman, Aartjan
    EARLY INTERVENTION IN PSYCHIATRY, 2014, 8 : 5 - 5
  • [39] THOUGHT-DISORDER AND COMMUNICATION PROBLEMS IN CHILDREN WITH SCHIZOPHRENIA SPECTRUM AND DEPRESSIVE-DISORDERS AND THEIR PARENTS
    TOMPSON, MC
    ASARNOW, JR
    GOLDSTEIN, MJ
    MIKLOWITZ, DJ
    JOURNAL OF CLINICAL CHILD PSYCHOLOGY, 1990, 19 (02): : 159 - 168
  • [40] Effects of Schizophrenia and Major Depressive Disorder on Subcortical Morphometry
    Gutman, Boris A.
    Hatton, Sean
    Alpert, Kathryn
    Kelly, Sinead
    Schmaal, Lianne
    Veltman, Dick
    Wang, Lei
    Thompson, Paul
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 168S - 169S